| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/14/2013 | CA2549114C Immunostimulant composition comprising at least one toll-like 7 receptor or toll-like 8 receptor agonist and a toll-like 4 receptor agonist |
| 05/14/2013 | CA2548202C Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 05/14/2013 | CA2547446C Solid forms of anti-egfr-antibodies |
| 05/14/2013 | CA2506696C Method for the prevention of malaria |
| 05/14/2013 | CA2468744C Hybrid antibodies |
| 05/14/2013 | CA2455915C Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 05/14/2013 | CA2453937C Antigenic polypeptides |
| 05/14/2013 | CA2393084C Immunoassay for neonicotinyl insecticides |
| 05/14/2013 | CA2388298C The use of csf-1 inhibitors |
| 05/14/2013 | CA2263890C Recombinant vascular endothelial cell growth factor d (vegf-d) |
| 05/14/2013 | CA2260079C Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 05/10/2013 | WO2013067415A1 Identification and use of protease inhibitors to treat or prevent sickle cell disease |
| 05/10/2013 | WO2013067098A1 Anti-kdr antibodies and methods of use |
| 05/10/2013 | WO2013067055A1 Methods of blocking cancer stem cell growth |
| 05/10/2013 | WO2013067054A1 Antibodies and methods of treating cancer |
| 05/10/2013 | WO2013066876A1 Anti-glucosaminidase passive immunization for staphylococcus aureus infections |
| 05/10/2013 | WO2013066818A1 USE OF AN ANTI-α-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF α-SYNUCLEIN IN THE BRAIN |
| 05/10/2013 | WO2013066780A2 Methods for reducing the frequency and severity of acute exacerbations of asthma |
| 05/10/2013 | WO2013066761A1 Method for preparing antibodies having improved properties |
| 05/10/2013 | WO2013066731A2 Protective vaccine based on staphylococcus aureus sa2451 protein |
| 05/10/2013 | WO2013066726A1 T-cell receptor clonotypes shared among ankylosing spondylitis patients |
| 05/10/2013 | WO2013066665A1 Method of rapidly producing improved vaccines for animals |
| 05/10/2013 | WO2013066471A2 Methods and compositions for preventing and treating an anthrax toxin mediated condition in a subject |
| 05/10/2013 | WO2013066365A1 Immunologic constructs and methods |
| 05/10/2013 | WO2013066272A1 Effect of an attenuated bordetella strain against allergic disease |
| 05/10/2013 | WO2013065708A1 Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain |
| 05/10/2013 | WO2013065019A1 Diagnostic and treatment of an androgen-independent prostate cancer |
| 05/10/2013 | WO2013064700A2 Chimeric polypeptides and methods of use |
| 05/10/2013 | WO2013064585A1 Treatment of musculoskeletal fibroproliferative disorders |
| 05/10/2013 | WO2013064584A1 Double-stranded RNA for immunostimulation |
| 05/10/2013 | WO2013064129A1 Adjuvants for polysaccharide vaccines and resulting formulations |
| 05/10/2013 | WO2013063874A1 Monoclonal antibody against human non-small-cell lung carcinoma and use thereof |
| 05/10/2013 | WO2013063702A1 Stable heterodimeric antibody design with mutations in the fc domain |
| 05/10/2013 | WO2013040472A3 Compositions and methods related to dna damage repair |
| 05/10/2013 | WO2013040391A3 Novel surface markers for adipose tissues |
| 05/10/2013 | WO2013037889A3 Vaccine |
| 05/10/2013 | WO2013036827A3 Fungal-specific metalloproteases and uses thereof |
| 05/10/2013 | WO2013036309A3 Sustained release formulations for delivery of proteins to the eye and methods of preparing same |
| 05/10/2013 | WO2013025538A3 Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease |
| 05/10/2013 | WO2013013025A3 Anti-cxcr4 antibodies and methods of use |
| 05/10/2013 | WO2012160448A3 Anti-kir antibodies for the treatment of inflammatory disorders |
| 05/10/2013 | WO2012128628A9 Immunogenic compositions in particulate form and methods for producing the same |
| 05/10/2013 | WO2011119487A3 Compositions and methods useful for stabilizing protein-containing formulations |
| 05/10/2013 | CA2854233A1 Stable heterodimeric antibody design with mutations in the fc domain |
| 05/10/2013 | CA2854153A1 Anti-kdr antibodies and methods of use |
| 05/10/2013 | CA2854110A1 Effect of an attenuated bordetella strain against allergic disease |
| 05/10/2013 | CA2854059A1 Diagnostic and treatment of an androgen-independent prostate cancer |
| 05/10/2013 | CA2853951A1 Antibodies and methods of treating cancer |
| 05/10/2013 | CA2853943A1 Anti-glucosaminidase passive immunization for staphylococcus aureus infections |
| 05/10/2013 | CA2853858A1 Methods for reducing the frequency and severity of acute exacerbations of asthma |
| 05/10/2013 | CA2853809A1 Method for preparing antibodies having improved properties |
| 05/10/2013 | CA2853671A1 Medical use |
| 05/10/2013 | CA2853230A1 Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain |
| 05/10/2013 | CA2849210A1 Antibody formulations |
| 05/10/2013 | CA2846074A1 Compositions and methods for treatment of metastatic cancer |
| 05/09/2013 | US20130117871 Human Antibodies Derived from Immunized Xenomice |
| 05/09/2013 | US20130116290 Use of Dipeptidyl Peptidase IV Effectors for Normalizing the Blood Glucose Level in Mammals |
| 05/09/2013 | US20130115658 Reversible, parallel and multitask cloning method and kit |
| 05/09/2013 | US20130115602 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 05/09/2013 | US20130115589 Pharmaceutical Composition for Treatment and Prevention of Herpes Virus Infections |
| 05/09/2013 | US20130115304 Compositions and methods for modulating immune response |
| 05/09/2013 | US20130115278 Peptide Epitopes of Apolipoprotein B |
| 05/09/2013 | US20130115277 Peptide Epitopes of Apolipoprotein B |
| 05/09/2013 | US20130115276 Peptide Epitopes of Apolipoprotein B |
| 05/09/2013 | US20130115275 Peptide Epitopes of Apolipoprotein B |
| 05/09/2013 | US20130115270 Anti-interleukin-1 (IL-1) antibody used as a targeting agent to treat arthritis and other diseases |
| 05/09/2013 | US20130115257 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
| 05/09/2013 | US20130115244 Immunogenic Substances Comprising a Polyinosinic Acid - Polycytidilic Acid Based Adjuvant |
| 05/09/2013 | US20130115243 Immunogenic formulations and their uses |
| 05/09/2013 | US20130115242 Modified Viral Strains and Method for Improving the Production of Vaccine Seeds of Influenza Virus |
| 05/09/2013 | US20130115240 Recombinant bcg strains with enhanced ability to inhibit intracellular mycobacterial growth |
| 05/09/2013 | US20130115238 Meningococcal fhbp polypeptides |
| 05/09/2013 | US20130115237 Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment |
| 05/09/2013 | US20130115236 Prophylaxis and treatment of prdc |
| 05/09/2013 | US20130115235 Swine influenza hemagglutinin variants |
| 05/09/2013 | US20130115234 Ectodomains of Influenza Matrix 2 Protein, Expression System, and Uses Thereof |
| 05/09/2013 | US20130115232 Methods for detecting graft-versus-host disease |
| 05/09/2013 | US20130115228 Immunostimulatory combinations |
| 05/09/2013 | US20130115224 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/09/2013 | US20130115222 Methods of limiting microvascular damage following acute myocardial ischemia |
| 05/09/2013 | US20130115221 HIFa prolyl hydroxylation assay |
| 05/09/2013 | US20130115220 Method for prevention or treatment of metabolic syndrome |
| 05/09/2013 | US20130115216 Survivin-derived peptides and uses thereof |
| 05/09/2013 | US20130115215 Domain insertion immunoglobulin |
| 05/09/2013 | US20130115214 Neuropilin antagonists |
| 05/09/2013 | US20130115213 Human cd3-specific antibody with immunosuppressive properties |
| 05/09/2013 | US20130115212 Modulation of the Interaction between SorLA and GDNF-Family Ligand Receptors |
| 05/09/2013 | US20130115211 Cytokine antagonists for neurological and neuropsychiatric disorders |
| 05/09/2013 | US20130115210 Peptide for Use in the Treatment of Breast Cancer and/or Bone Metastases |
| 05/09/2013 | US20130115206 Compositions and Methods for Treating and Diagnosing Cancer |
| 05/09/2013 | US20130115191 T cell receptor fusions and conjugates and methods of use thereof |
| 05/09/2013 | US20130115189 Use of Interleukin-1 Beta Mutein Conjugates in the Treatment of Diabetes |
| 05/09/2013 | US20130115188 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers |
| 05/08/2013 | EP2589963A1 Diagnostic and treatment of an androgen-independent prostate cancer |
| 05/08/2013 | EP2589654A1 CD40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity |
| 05/08/2013 | EP2589610A1 Human c-fms antigen binding proteins |
| 05/08/2013 | EP2589604A1 Truncated l1 protein of human papillomavirus type 52 |
| 05/08/2013 | EP2589602A2 Development of dengue virus vaccine components |
| 05/08/2013 | EP2589392A2 Process for stabilizing an adjuvant containing vaccine composition |
| 05/08/2013 | EP2589391A2 Method for treating and diagnosing cancer by using cell-derived microvesicles |